[PDF] Top 20 Desenvolvimento de substrato cerâmico BiNbO4 para antenas de microfita de sistemas de comunicações sem fio
Has 10000 "Desenvolvimento de substrato cerâmico BiNbO4 para antenas de microfita de sistemas de comunicações sem fio" found on our website. Below are the top 20 most common "Desenvolvimento de substrato cerâmico BiNbO4 para antenas de microfita de sistemas de comunicações sem fio".
Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
... with warfarin dosage such as age, sex, body mass, race and ...in warfarin dosing. 3,11,12 S-warfarin enantiomer is particularly metabolized by hepatic cytochrome P450 2C9 and contributes to 70% of ... See full document
5
<p>Polymorphisms of <em>CYP2C9*2</em>, <em>CYP2C9*3</em> and <em>VKORC1</em> genes related to time in therapeutic range in patients with atrial fibrillation using warfarin</p>
... during therapy initiation? Curr Mol ...M. Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese ...A. CYP2C9 polymorphism and unstable ... See full document
15
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
... 100 patients years during oral anticoagulant therapy ...of CYP2C9 polymor- phisms had higher occurrence of bleeding than non-carri- ers during warfarin ...reduced CYP2C9 and/or ... See full document
47
Original Article CYP2C9 and VKORC1 genotype-guided individualized warfarin therapy in Chinese patients with acute pulmonary thromboembolism: a randomized controlled clinical study
... of warfarin is highly vari- able, both interindividually and interethnically ...The polymorphisms of both metabolic enzyme CYP2C9 and target gene VKORC1 (Vitamin K epoxide reductase subunit 1) ... See full document
121
Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
... 214 patients with warfarin anticoagulant therapy were ...maintenance warfarin therapy with a stable, therapeutic INR between 2 and ...daily warfarin requirement was from ...the ... See full document
6
Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
... to warfarin sensitivity. Variations in VKORC1 have been associated with both warfarin sensitivity and warfarin ...of VKORC1 polymorphism has been reported in literature as 37% for ... See full document
5
Combined effect of CYP2C9 and VKORC1 polymorphisms on warfarin maintenance dose in Omani patients
... anticoagulant therapy, target INR range, con- comitant disease, concomitant medications, and dietary information were collected from the medical charting system and ...All patients were individually ... See full document
138
Original Article High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9
... poor warfarin control with risk of throm- bosis and bleeding events is highest during the first months of treatment ...genetic polymorphisms of the vitamin K epoxide reduc- tase [VKORC1] and ... See full document
18
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
... genetic polymorphisms. Genetic polymorphisms occurring as a result of single- nucleotide exchange in the DNA sequence are more frequent, whereas others occurring as a result of either insertions or ... See full document
8
Use of warfarin in long-term care: a systematic review
... receiving warfarin, INRs are in the target range approximately half of the time ...residents who fall out of target range are ...diet, warfarin prescribing and INR monitoring appear less than opti- ... See full document
36
APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population
... The study groups included 262 pathologically confirmed BC patients with an average age of 48.9± 11.2 years and 217 healthy women with a mean age of 50.0± 13.0 years. The demographic information of patients ... See full document
26
A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children
... a warfarin decision support ...for warfarin developed in NONMEM to a platform independent tool written in ...of warfarin with a performance comparable to ...optionally CYP2C9 and VKORC1 ... See full document
7
CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve Replacement
... study, patients possessing mu- tated allelic variants of the CYP2C9 gene had lower both estimated and actual warfarin doses than pa- tients with the CYP2C9*1/*1 ...Lithuanian patients ... See full document
21
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
... 207 patients were treated with warfarin in two phases; the first phase is called the initiation phase of the treatment, which is defined as the phase in which initially the INR value of the patient is ... See full document
12
<p>Effects of Apatinib on the Pharmacokinetics of Nifedipine and Warfarin in Patients with Advanced Solid Tumors</p>
... the therapy targeting tumor vasculatures including ...Moreover, warfarin is the index substrate of CYP2C9 with a narrow therapeutic ...on warfarin could be representative of the effects on ... See full document
18
Warfarin Therapy in Children Who Require Long-Term Total Parenteral Nutrition
... 15.2 warfarin years were studied ...of warfarin required to achieve the target therapeutic range (international nor- malized ratio) of ...between warfarin monitoring tests was ...ticoagulant ... See full document
6
INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.
... This study was performed to study the difference in clinical, biochemical, histological parameters and genotypes of IL28B between responders and non responders to standard of care (SOC) therapy, to find out the ... See full document
6
Warfarin-induced calciphylaxis: a case report and review of literature
... Supportive treatment includes wound and pain management. Some success has been achieved with hyper- baric oxygen and intravenous sodium thiosulfate therapy. Correction of hypercalcemia and hyperphosphatemia is ... See full document
10
Warfarin Therapy: Survey of Patients Knowledge of their Drug Regimen
... taking warfarin was ...the patients knew of any possible adverse effects of ...(12). Patients are warned that normal adverse effects include easy bruising and hemorrhage ... See full document
20
Influence of Vitamin K Epoxide Reductase Complex 1 Gene Polymorphisms on Anticoagulation with Acenocoumarol in Patients with Cerebral Venous Thrombosis
... VKORC1 -1639G>A polymorphism has been reported to be associated with decreased enzyme activity and thus lower dose requirement in the carriers of the mutant alleles [27]. A study on Romanian population showed a ... See full document
11
Related subjects